| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $30.0M | +1016.5% |
| R&D Expense | $67.0M | +25.1% |
| SG&A Expense | $24.9M | -1.0% |
| Operating Income | -$61.9M | +18.6% |
| Interest Expense | $3.1M | +23.6% |
| Pre-tax Income | -$63.6M | +19.0% |
| Net Income | -$63.6M | +19.0% |
| EPS (Basic) | -$1.14 | +35.6% |
| EPS (Diluted) | -$1.14 | +35.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $50.9M | -9.2% |
| Current Assets | $129.1M | -17.9% |
| Total Assets | $159.9M | -16.2% |
| Current Liabilities | $16.3M | -18.8% |
| Total Liabilities | $66.5M | -7.6% |
| Stockholders' Equity | $93.4M | -21.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$59.6M | +4.5% |
| Capital Expenditures | $497K | +314.2% |
| Investing Cash Flow | $22.8M | +122.9% |
| Financing Cash Flow | $31.7M | -25.5% |
| Free Cash Flow | -$60.0M | +3.9% |